EP4125881
Ný notkun á angíótensín II viðtakaörva af gerð 2
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.3.2021EP published:
24.7.2024EP application number:
21715306.3
EP translation filed:
14.10.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
21.3.2041Expiry date:
21.3.2027Next due date:
31.3.2027
Title in English:
NEW USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONISTLanguage of the patent:
English
Timeline
Today
22.3.2021EP application
24.7.2024EP Publication
14.10.2024Translation submitted
15.11.2024Registration published
21.3.2027Expires
Owner
Name:
Vicore Pharma ABAddress:
Kornhamnstorg 53, 111 27 Stockholm, SE
Inventor
Name:
DALSGAARD, Carl-JohanAddress:
111 27 Stockholm, SE
Name:
RAUD, JohanAddress:
111 27 Stockholm, SE
Name:
BATTA, RohitAddress:
111 27 Stockholm, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202004209Date:
23.3.2020Country:
GB
Number:
202009574Date:
23.6.2020Country:
GB
Number:
202017113416Date:
7.12.2020Country:
US
Classification
Categories:
A61K 31/4178, A61K 31/573, A61K 31/706, A61K 38/21, A61K 45/06, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 27.3.2025
Expires: 21.3.2026
Payer: Árnason Faktor ehf.
Number: 6
Paid: 24.3.2026
Expires: 21.3.2027
Payer: iPify